School of Basic Medical Science, Xi’an Key Laboratory of Pathogenic Microorganism and Tumor Immunity, Xi’an Medical University, Xi’an 710021, China School of Biotechnology and Health Sciences, Wuyi ...

The ChemoFx® treatment selection marker and tumor profiling assay will initially focus on ovarian and other gynecological cancers and may include testing of other major tumor types of interest ...

(NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated flagship live cell ChemoFx® drug response assay in Europe and expanded availability in the United ...

Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China Background: The high morbidity and mortality rates of colorectal ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...

Sphere Fluidics, announced the launch of Cyto-Mine ® Chroma and the opening of its ... the Company will collaborate closely with forward-thinking customers to drive innovation and inform the ...

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics ... innovation and inform the development of future applications and assays on the platform. Offering enhanced capabilities, including ...